Brain-Stomach Circuits in Chronic Nausea
David Levinthal · with National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · NCT07276035
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 21–60 · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 219
- US sites recruiting
- 1
- Study start
- January 28, 2026
- Record last updated
- July 24, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
The goal of this study is to determine whether stimulation of the brain-stomach connection can influence stomach activity in healthy adults and in individuals suffering from chronic nausea. The main questions it aims to answer are:
- What are the best brain sites to influence the stomach?
- What are the effects of different stimulation patterns on stomach activity?
- Does the stimulation affect the sensation of nausea in participants suffering from chronic nausea?
Researchers will use a non-invasive method of brain stimulation called Transcranial Magnetic Stimulation (TMS) and will record stomach responses with skin electrodes on the abdomen.
Participants will
- Visit the clinic at least once, and for up to 9 times more over the course of several months.
- Receive TMS while sitting in a chair similar to a dentist's chair.
- Drink water or consume a test meal during each study visit.
Being studied: Transcranial Magnetic Stimulation, TMS
Conditions: Chronic Nausea and Vomiting Syndrome
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Adults between ages 21-60 years old, with and without CNVS diagnosis per self-report.
Exclusion Criteria
- body mass index (BMI) > 30
- pregnancy or intention to become pregnant
- past or present chemotherapy
- diagnosis of gastric (stomach) cancer
- any kind of gastric (stomach) surgery
- current use of GLP-1 receptor agonists (e.g. Ozempic, Trulicity)
- medications which significantly lower seizure thresholds (e.g. bupropion (Wellbutrin), fluoxetine (Prozac), or tramadol (Ultram))
- implantable devices, such as a pacemakers or nerve stimulators
- history of head injury that required hospitalization, metal in the skull, or neurologic disease such as stroke, history of seizures or history of syncope (fainting or passing out)
- neurodegenerative disease (Multiple Sclerosis, Parkinson's or Alzheimer's Disease)
- ongoing psychosis or altered cognitive status status (e.g. hearing sounds or seeing visions that are not there, or feeling confused or suffering from memory lapses)
- history of cardiovascular (i.e., heart attack), pulmonary (i.e., need for supplemental oxygen), or endocrine disease (e.g. diabetes)
- current enrollment in another study using Transcranial Magnetic Stimulation (TMS)
- current use of drugs such as amphetamines, methamphetamine, Ecstasy, Ketamine, Angel Dust/PCP, cocaine, or drinking 3 or more alcoholic drinks per day
- For healthy subjects only: chronic history of gastrointestinal symptoms (e.g., nausea, indigestion, bloating, abdominal pain)
- For CNVS subjects only: diagnosis of gastric motility disorder (e.g. gastroparesis/slow stomach emptying) or history of bowel obstruction (i.e., chronic partial small bowel obstruction)
Recruiting US locations
University of Pittsburgh Medical Center
Pittsburgh, PA 15232
Study contacts (from the official record)
- Elijah D Wright · 412-647-1228 · edw87@pitt.edu
- David J Levinthal, MD PhD · 412-303-0525 · levinthald@upmc.edu
Similar studies in Pennsylvania
All healthy volunteers studies in Pennsylvania →- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
Intralesional 5-Fluorouracil (5FU), Topical Calcipotriene Treatment for SCC
Melissa Pugliano-Mauro
- Location
- Pittsburgh, PA
- Eligibility basics
- Ages 18+
- RecruitingHealthy volunteersPhase 1/Phase 2
A Phase I/II Study of ITU512 in Healthy Participants and Patients With Sickle Cell Disease
Novartis Pharmaceuticals
- Location
- Philadelphia, PA + 7 other US sites
- Eligibility basics
- Ages 12–55
- RecruitingHealthy volunteersPhase 1/Phase 2
Phase 1/2 Study of Respiratory Syncytial Virus and Human Metapneumovirus (RSV+HMPV) Vaccine Candidate in Adults 60 Years of Age and Older
Sanofi
- Location
- Philadelphia, PA + 49 other US sites
- Eligibility basics
- Ages 60+
- RecruitingHealthy volunteersPhase 1
A Research Study Looking at How Different Doses of Study Medicine (Inno8) Work in the Body of People With Haemophilia A
Novo Nordisk A/S
- Location
- Hershey, PA + 4 other US sites
- Eligibility basics
- Ages 18–64 · Men only